We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New MRI Technology Uses Krypton Gas as Contrast Agent

By HospiMedica International staff writers
Posted on 20 Mar 2016
A new magnetic resonance imaging (MRI) scanning technology that uses Krypton gas as an inhalable contrast agent could provide insights on lung disease.

Under development by researchers at the University of Nottingham (United Kingdom), the novel technique uses lasers to hyperpolarize the nuclei of a noble gas, aligning them so that the inert gas becomes visible on an MRI scan. More...
While traditional MRI uses hydrogen protons in the body as molecular targets, this does not give a detailed picture of the lungs, since they are full of air. The new technique will make three dimensional (3D) imaging of the lungs possible, and could also be used with other inhaled, hyperpolarized, noble gases, such as helium and xenon-129.

The new method is made possible via catalytic hydrogen combustion, a process associated with clean energy related sciences. In the process, krypton-83 gas is mixed with molecular hydrogen as the buffer in laser spin-exchange optical pumping (SEOP). After laser pumping, the hydrogen gas is mixed with molecular oxygen, “exploding” it away in a controlled fashion via catalyzed combustion, leaving behind high-purity, hyperpolarized krypton gas. The study describing the catalytic process was published on March 9, 2016, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).

“Remarkably, the hyperpolarized state of krypton-83 ‘survives’ the combustion event. Water vapor, the sole product of the ‘clean’ hydrogen reaction, is easily removed through condensation, leaving behind the purified laser-polarized krypton-83 gas diluted only by small remaining quantities of harmless water vapor,” said senior author Prof. Thomas Meersmann, PhD, chair of translational imaging. “This development significantly improves the potential usefulness of laser-pumped krypton-83 as MRI contrast agent for clinical applications.”

The hyperpolarized state is very low spin temperature condition that is not in a thermal equilibrium with the temperature of the sample. Low spin temperature leads to high magnetization of the spin ensemble, which results in a very high nuclear magnetic resonance signal intensity. This eventually returns to the depolarized thermal equilibrium temperature. Of the quadrupolar noble gas isotopes, krypton-83 is most likely to serve as a surface sensitive MRI contrast agent, since it displays a slower relaxation compared to xenon as a result of its smaller electron cloud and its larger nuclear spin.

Related Links:

University of Nottingham



New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Wound Irrigation Solution
Prontosan®
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.